Comments on: Why biotechs like CombinatoRx (CRXX) make the best penny share speculations http://www.todaysfinancialnews.com/investment-strategies/why-biotechs-like-combinatorx-crxx-make-the-best-penny-share-speculations-10389.html Today's Financial News offers an independent and very practical perspective on the U.S. and global investment markets. We filter out exactly what financial news is worth paying attention to... and what it means for your money and portfolio Tue, 26 Jan 2010 12:08:21 -0500 http://wordpress.org/?v=2.8.5 hourly 1 By: Robert Ganoosh http://www.todaysfinancialnews.com/investment-strategies/why-biotechs-like-combinatorx-crxx-make-the-best-penny-share-speculations-10389.html#comment-5383 Robert Ganoosh Fri, 20 Nov 2009 14:17:05 +0000 http://www.todaysfinancialnews.com/?p=10389#comment-5383 Great article! "There’s revenues at stake… but more so, control of the combined company." This is EXACTLY why Neuromed and CombinatoRx won't be dropping the ball on Exalgo approval. This whole fiasco with the NDA is only a good thing for current CRXX shareholders. Great article!

“There’s revenues at stake… but more so, control of the combined company.”

This is EXACTLY why Neuromed and CombinatoRx won’t be dropping the ball on Exalgo approval. This whole fiasco with the NDA is only a good thing for current CRXX shareholders.

]]>